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Abstract 
 
Amyloid cleaving enzyme-1 (BACE1) is a target of interest for treating patients with 
Alzheimer’s disease (AD).  As of 2007, more than 37 million people worldwide are afflicted 
with the disease.  Incidence of the disease keeps increasing as the population ages and 
fewer people die of other diseases.   ß-Amyloid precursor protein (APP) is a natural protein 
associated with neurons of the brain.  In Alzheimer's disease, APP is cleaved by BACE1 at the 
beta-site, resulting in short 42 amino acid segments called amyloid-ß (Aß).  Aggregation of Aß 
into plaques results in the death of neurons and is associated with AD.  Inhibition of the BACE1 
enzyme may prevent Aß formation and prevent the development or progression of AD.   Known 
BACE1 inhibitors are analyzed using computational chemistry techniques, and quantitative 
structure-activity relationships (QSAR) are developed. 
 
